Hu WH - Search Results

1

Role of sequential chemoradiotherapy in stage II and low-risk stage III-IV nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: A propensity score-matched analysis.

Xu C, Sun R, Tang LL, Chen L, Li WF, Mao YP, Zhou GQ, Guo R, Lin AH, Sun Y, Ma J, Hu WH. Xu C, et al. Among authors: hu wh. Oral Oncol. 2018 Mar;78:37-45. doi: 10.1016/j.oraloncology.2018.01.008. Epub 2018 Feb 20. Oral Oncol. 2018. PMID: 29496056

2

[Change in visual evoked potential by radiotherapy of nasopharyngeal carcinoma].

Hu W, Yu M, Long S, Huang S, Gu M, Zhou L, Wu D. Hu W, et al. Zhonghua Zhong Liu Za Zhi. 2002 Mar;24(2):147-50. Zhonghua Zhong Liu Za Zhi. 2002. PMID: 12015036 Chinese.

3

[Prognostic factors of 60 nasal cavity carcinoma patients].

Hu W, Xie F, Chen D, Chen M, He D, Mao Z, Pan G. Hu W, et al. Zhonghua Zhong Liu Za Zhi. 2002 Nov;24(6):592-4. Zhonghua Zhong Liu Za Zhi. 2002. PMID: 12667333 Chinese.

4

[Changes of visual field and visual evoked potential in nasopharyngeal carcinoma patients after radiotherapy].

Pan Y, Hu WH, Gao Y, Yu MZ, Huang SZ. Pan Y, et al. Among authors: hu wh. Ai Zheng. 2005 Jun;24(6):722-6. Ai Zheng. 2005. PMID: 15946488 Chinese.

5

[Retrospective analysis of 934 nasopharyngeal carcinoma patients treated with conventional external beam radiotherapy alone].

Lu TX, Zhao C, Wu SX, Luo W, Chen Y, Xie FY, Chen M, Zeng XF, Hu WH, Cao XP, Xia YF, Liu XF, Cui NJ. Lu TX, et al. Among authors: hu wh. Zhonghua Zhong Liu Za Zhi. 2005 Oct;27(10):620-2. Zhonghua Zhong Liu Za Zhi. 2005. PMID: 16438874 Chinese.

6

[Quality of life of 192 disease-freely survival nasopharyngeal carcinoma patients after radiotherapy].

Wu Y, Hu WH, Xia YF, Ma J, Liu MZ, Cui NJ. Wu Y, et al. Among authors: hu wh. Ai Zheng. 2005 Nov;24(11):1376-83. Ai Zheng. 2005. PMID: 16552967 Chinese.

7

Quality of life of nasopharyngeal carcinoma survivors in Mainland China.

Wu Y, Hu WH, Xia YF, Ma J, Liu MZ, Cui NJ. Wu Y, et al. Among authors: hu wh. Qual Life Res. 2007 Feb;16(1):65-74. doi: 10.1007/s11136-006-9113-0. Epub 2006 Oct 11. Qual Life Res. 2007. PMID: 17033899

8

[Phase II clinical trial of h-R3 combined radiotherapy for locoregionally advanced nasopharyngeal carcinoma].

Wu RR, Wu SX, Zhao C, Xie FY, Gao JM, Hu WH, Gao YH, Li FY, Cui TT, Lu TX. Wu RR, et al. Among authors: hu wh. Ai Zheng. 2007 Aug;26(8):874-9. Ai Zheng. 2007. PMID: 17697551 Free article. Clinical Trial. Chinese.

9

[Long-term efficacy of induction chemotherapy plus concurrent radiochemotherapy on advanced nasopharyngeal carcinoma].

Liang Y, Gao JM, Hu WH, Gao YH, Xie FY. Liang Y, et al. Among authors: hu wh. Ai Zheng. 2007 Aug;26(8):885-9. Ai Zheng. 2007. PMID: 17697553 Free article. Chinese.

10

[Induction chemotherapy with docetaxel plus cisplatin (TP regimen) followed by concurrent chemoradiotherapy with TP regimen versus cisplatin in treating locally advanced nasopharyngeal carcinoma].

Xie FY, Zou GR, Hu WH, Qi SN, Peng M, Li JS. Xie FY, et al. Among authors: hu wh. Ai Zheng. 2009 Mar;28(3):279-85. Ai Zheng. 2009. PMID: 19619443 Free article. Clinical Trial. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

508 results

Search Page

Filters